Kobrynski and Sullivan [9] report that the specific gene responsible for the clinical presentation of velocardiofacial syndrome, called the TBX1 gene, was identified in 2001; however, at the locus of chromosome 22 in which the deletion occurs, there are more than 35 other genes. Here, TBX1 is linked to 22q11.2 deletion syndrome.